These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1333927)

  • 21. [Peripheral neuropathy in a sporadic case of cerebrotendinous xanthomatosis].
    Ben Hamida M; Chabbi N; Ben Hamida C; Mhiri C; Kallel R
    Rev Neurol (Paris); 1991; 147(5):385-8. PubMed ID: 1649488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrotendinous xanthomatosis: clinical and laboratory study of 2 cases.
    Canelas HM; Quintão EC; Scaff M; Vasconcelos KS; Brotto MW
    Acta Neurol Scand; 1983 May; 67(5):305-11. PubMed ID: 6410671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use.
    Kuriyama M; Tokimura Y; Fujiyama J; Utatsu Y; Osame M
    J Neurol Sci; 1994 Aug; 125(1):22-8. PubMed ID: 7964884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Tint GS
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT and MRI findings of xanthoma in the orbitofrontal region.
    Matoba M; Tonami H; Kuginuki M; Yamamoto I; Akai T; Iizuka H
    Radiat Med; 2004; 22(2):116-9. PubMed ID: 15176607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cerebrotendinous xanthomatosis: report of one case].
    Filippi J; Irarrázaval S; Peredo P; Mellado P
    Rev Med Chil; 2009 Jun; 137(6):815-20. PubMed ID: 19746285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrotendinous xanthomatosis with cholestanolaemia--involvement of five individuals in a Malay family.
    Othman NH; Rahman SA
    Med J Malaysia; 1990 Dec; 45(4):275-80. PubMed ID: 2152046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis.
    Berginer VM; Shany S; Alkalay D; Berginer J; Dekel S; Salen G; Tint GS; Gazit D
    Metabolism; 1993 Jan; 42(1):69-74. PubMed ID: 8446051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrotendinous xanthomatosis.
    Kearns WP; Wood WS
    Arch Ophthalmol; 1976 Jan; 94(1):148-50. PubMed ID: 1247403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrotendinous xanthomatosis: neuroimaging findings in two siblings from an Indian family.
    Gaikwad SB; Garg A; Mishra NK; Gupta V; Srivastava A; Sarkar C
    Neurol India; 2003 Sep; 51(3):401-3. PubMed ID: 14652454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrotendinous xanthomatosis (cholestanolosis). Investigations on two sisters and their family.
    Schreiner A; Hopen G; Skrede S
    Acta Neurol Scand; 1975 May; 51(5):405-16. PubMed ID: 1130172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adrenoleukodystrophy with high signal intensity areas in bilateral pyramidal tracts from internal capsule through medullary pyramids on MRI].
    Kitagawa Y; Koto A; Yagishita A; Matsuoka Y; Koike R
    Rinsho Shinkeigaku; 1989 May; 29(5):606-11. PubMed ID: 2791411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A central nervous system lupus showing peculiar findings on cranial magnetic resonance imaging (MRI)].
    Takahashi T; Kokubun Y; Okuhata Y; Sawada S; Mizutani T
    Rinsho Shinkeigaku; 2003 Jul; 43(7):409-16. PubMed ID: 14582367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parkinsonism in cerebrotendinous xanthomatosis.
    Fujiyama J; Kuriyama M; Yoshidome H; Suehara M; Eiraku N; Kashio N; Osame M
    Jpn J Med; 1991; 30(2):189-92. PubMed ID: 1865593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations.
    Moghadasian MH; Salen G; Frohlich JJ; Scudamore CH
    Arch Neurol; 2002 Apr; 59(4):527-9. PubMed ID: 11939886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Investigation of involvement of cerebral white matter in DRPLA--including MRI perfusion study].
    Mizoi Y; Segawa F; Kamada K; Sunohara N; Nakayama H; Akashi T
    No To Shinkei; 1994 Feb; 46(2):145-51. PubMed ID: 8167052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type IIa hyperlipoproteinemia masquerading as cerebrotendinous xanthomatosis.
    Ijichi S; Ijichi N; Niina K; Kuriyama M; Izumo S; Nakamura F; Osame M
    J Neurol Sci; 1989 Dec; 94(1-3):101-5. PubMed ID: 2614461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Van Bogaert's cerebrotendinous xanthomatosis. A study of 3 cases].
    Laurent A; Dairou F; Luc G; Truffert J; Lapresle J; de Gennes JL
    Ann Med Interne (Paris); 1988; 139(6):395-402. PubMed ID: 3066249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A 29-year-old man with diabetes insipidus and cerebellar ataxia and development of spinal cord swelling 15 years after the onset].
    Ohkuma Y; Sato K; Ohtomo T; Ohishi H; Mitsuoka H; Mori H; Hirai S; Takubo H; Takeda N; Sato K; Mizuno Y
    No To Shinkei; 1997 May; 49(5):473-81. PubMed ID: 9163763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Late cerebellar ataxia associated with fragile X premutation].
    Chaussenot A; Borg M; Bayreuther C; Lebrun C
    Rev Neurol (Paris); 2008 Nov; 164(11):957-63. PubMed ID: 18808779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.